Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 23

Trial Status

Completed2
Terminated1

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT05045248Phase 2Completed
Efficacy of Apraclonidine Eye Drops in the Treatment of Ptosis Secondary to Myasthenia Gravis
Myasthenia GravisOcular Myasthenia Gravis
PrincipalinvestigatorStart date: 2020-06-01
NCT03377309Phase 2Terminated
Safety and Tolerability of Perampanel in Amyotrophic Lateral Sclerosis Patients
Amyotrophic Lateral Sclerosis
PrincipalinvestigatorStart date: 2019-12-01
NCT03427086Phase 2Completed
Safety and Tolerability of High Dose Biotin in Patients With Amyotrophic Lateral Sclerosis
Amyotrophic Lateral Sclerosis
PrincipalinvestigatorStart date: 2018-01-29

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

American University of Beirut Medical Center

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Seward Rutkove, MD

Beth Israel Deaconess Medical Center

Related
5 trials

Shared therapeutic areas:

Amyotrophic Lateral SclerosisMyasthenia Gravis
Similarity Score20%

Achraf Makki, MD

American University of Beirut Medical Center

Related
1 trials

Shared therapeutic areas:

Amyotrophic Lateral Sclerosis

Worked with same sponsors:

American University of Beirut Medical Center
Collaborated on 1 trial
Similarity Score14%

Qiubai Li, Professor

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Related
7 trials

Shared therapeutic areas:

Myasthenia Gravis
Similarity Score10%

loic MONDOLONI

Assistance Publique Hopitaux De Marseille

Related
28 trials

Shared therapeutic areas:

Amyotrophic Lateral Sclerosis
Similarity Score10%

Hamid Gourabi, PhD

head of Royan Institute

Related
52 trials

Shared therapeutic areas:

Amyotrophic Lateral Sclerosis
Similarity Score10%

Jane Huggins, PhD

University of Michigan

Related
6 trials

Shared therapeutic areas:

Amyotrophic Lateral Sclerosis
Similarity Score10%

Sabine Hazan, MD

ProgenaBiome

Related
41 trials

Shared therapeutic areas:

Amyotrophic Lateral Sclerosis
Similarity Score10%

Barbara Borroni, MD

Azienda Ospedaliera Spedali Civili, Brescia

Related
7 trials

Shared therapeutic areas:

Amyotrophic Lateral Sclerosis
Similarity Score10%

Urielle Desalbres

Assistance Publique Hôpitaux de Marseille

Related
71 trials

Shared therapeutic areas:

Amyotrophic Lateral Sclerosis
Similarity Score10%

He Huang, MD

Zhejiang University

Related
10 trials

Shared therapeutic areas:

Myasthenia Gravis
Similarity Score10%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT05045248Phase 2PrincipalInvestigator

Efficacy of Apraclonidine Eye Drops in the Treatment of Ptosis Secondary to Myasthenia Gravis

Myasthenia GravisOcular Myasthenia Gravis
Completed
NCT03377309Phase 2PrincipalInvestigator

Safety and Tolerability of Perampanel in Amyotrophic Lateral Sclerosis Patients

Amyotrophic Lateral Sclerosis
Terminated
NCT03427086Phase 2PrincipalInvestigator

Safety and Tolerability of High Dose Biotin in Patients With Amyotrophic Lateral Sclerosis

Amyotrophic Lateral Sclerosis
Completed

All 3 trials loaded